A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy
Aim. Evaluation of the effectiveness of anti-interleukin drugs used in the pathogenetic therapy of COVID-19 in relation to the relative risks of 28-day mortality and the odds ratio of 14-day improvement of symptoms of the disease. Materials and methods. A systematic review of publications concerning...
Saved in:
Main Authors: | Yu. M. Gomon, A. S. Kolbin, A. M. Fahrutdinova, T. A. Usmanova, F. M. Sultanova, Yu. E. Balykina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2023-07-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of interleukin-6 and interleukin-8 in serum from women with recurrent spontaneous abortion
by: Baghdad Science Journal
Published: (2010-09-01) -
Cardiometabolic risk factors and their relationship with the interleukin-6 receptor gene polymorphism (rs2228145) in patients with hypertrophic cardiomyopathy
by: T. G. Bezhanishvili, et al.
Published: (2020-11-01) -
Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
by: Evgeny L. Nasonov, et al.
Published: (2024-09-01) -
Interleukin Activity in Miscarried Women with Toxoplasmosis and Anti Thyroid Peroxidase (Anti-TPO)
by: Salah Alnisani, et al.
Published: (2025-06-01) -
New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)